DIAbetes and diffuse coronary Narrowing Analysis Study.

Trial Profile

DIAbetes and diffuse coronary Narrowing Analysis Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Nateglinide (Primary) ; Voglibose (Primary)
  • Indications Coronary artery disease; Glucose intolerance; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms DIANA
  • Most Recent Events

    • 26 Mar 2010 New trial record
    • 15 Mar 2010 Results presented at the 59th Annual Scientific Session of the American College of Cardiology (ACC 2010).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top